Novel continuous flow technology for the development of a nanostructured Aprepitant formulation with improved pharmacokinetic properties Article

Angi, Reka, Solymosi, Tamas, Oetvoes, Zsolt et al. (2014). Novel continuous flow technology for the development of a nanostructured Aprepitant formulation with improved pharmacokinetic properties . 86(3), 361-368. 10.1016/j.ejpb.2013.10.004

cited authors

  • Angi, Reka; Solymosi, Tamas; Oetvoes, Zsolt; Ordasi, Betti; Glavinas, Hristos; Filipcsei, Genoveva; Heltovics, Gabor; Darvas, Ferenc

sustainable development goals

authors

publication date

  • April 1, 2014

keywords

  • ABSORPTION
  • ANTAGONIST
  • Aprepitant
  • BIOAVAILABILITY
  • Bioavailability
  • CLASSIFICATION
  • CYTOCHROME-P450 3A4
  • Continuous flow nanoprecipitation
  • DISSOLUTION
  • Food effect
  • In vitro/in vivo correlation
  • Life Sciences & Biomedicine
  • MODEL
  • Pharmacology & Pharmacy
  • SIZE
  • Science & Technology
  • Solubility
  • WATER-SOLUBLE DRUGS

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE BV

start page

  • 361

end page

  • 368

volume

  • 86

issue

  • 3